A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 138,591 shares of ADMA stock, worth $2.96 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
138,591
Previous 117,919 17.53%
Holding current value
$2.96 Million
Previous $1.32 Million 110.17%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$11.21 - $20.03 $231,733 - $414,060
20,672 Added 17.53%
138,591 $2.77 Million
Q2 2024

Aug 14, 2024

BUY
$5.98 - $11.18 $705,155 - $1.32 Million
117,919 New
117,919 $1.32 Million

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $4.2B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.